exoASO-C/EBP beta

N/A

Report date: 2025/10/28 15:11:28

NME

Base Information

Drug NameexoASO-C/EBP beta

Drug Alias NameC/EBP beta inhibitor (Codiak BioSciences)ExoASO-C/EBP Beta (Codiak BioSciences)Antisense Oligonucleotide Loaded Engineered Exosome (Codiak BioSciences)

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense

Mechanisms of ActionCCAAT/enhancer-binding protein beta inhibitors

TargetsCCAAT/enhancer-binding protein beta

Therapy Area/IndicationsFibrosisNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCodiak BioSciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesCodiak BioSciences Inc

Inactive CompaniesN/A

Active IndicationsFibrosisNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A